D1. What are the subgroups for clinical trials in
recurrent ovarian cancer? Defining patient cohorts
•
Type and presence of symptoms
–
Ascitis, abdominal symptoms, pain
–
PS
•
Number of prior chemotherapy lines
–
Patients with multiple prior lines (>3) are considered as having an
unmet medical need and there is a need of trials beyond 3rd line
•
Tumor volume
•
Previous surgery for recurrence
–
Collect residual tumor after surgery as potential prognosis factor
•
Specific trials for elderly and frails patients was identified as unmet
medical need
5th OCCC of the GCIG: Recurrent Disease. Ann Oncol. 2016 Dec 19
